PHARMA INTELLIGENCE U.K. LIMITED
Get an alert when PHARMA INTELLIGENCE U.K. LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Cash
£11K
-98.4% vs 2023
Net assets
-£13M
-5,240.7% vs 2023
Employees
381
+56.1% vs 2023
Profit before tax
-£18M
-31% vs 2023
Watchouts
Facts from the Companies House register and the latest accounts — not a rating
-
Audit opinion: Qualified
Latest auditor's report carried a non-clean opinion.
-
Negative shareholders' funds
Net assets
2-year trend · vs Consumer Discretionary median
Accounts
2-year trend · Δ = latest vs prior filed period · latest reflected 2024-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 | Δ vs prior |
|---|---|---|---|---|
| Turnover | £56,511,000 | £66,129,000 | +17% | |
| Operating profit | -£8,579,000 | -£3,232,000 | +62.3% | |
| Profit before tax | -£13,854,000 | -£18,144,000 | -31% | |
| Net profit | -£14,579,000 | -£19,140,000 | -31.3% | |
| Cash | £691,000 | £11,000 | -98.4% | |
| Total assets less current liabilities | -£243,000 | -£12,978,000 | -5,240.7% | |
| Net assets | -£243,000 | -£12,978,000 | -5,240.7% | |
| Equity | -£243,000 | -£12,978,000 | -5,240.7% | |
| Average employees | 244 | 381 | +56.1% | |
| Wages | £19,576,000 | £33,626,000 | +71.8% | |
| Directors' remuneration | — | £521,000 | — |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show —. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating margin | -15.2% | -4.9% | |
| Net margin | -25.8% | -28.9% | |
| Current ratio | 0.98x | 0.80x | |
| Interest cover | -6.05x | -6.44x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 101
- Reporting scope
- Standalone (parent only)
- Auditor
- Ernst & Young LLP
- Audit opinion
- Qualified
- Going concern
- Affirmed
“The Company is dependent on the Ultimate Parent for financial support. As stated in the "Going concern" section of the Directors' Report, the Company has obtained a letter of support from the Ultimate Parent which confirms its intent to provide sufficient financial support to enable the Company to meet its obligations as and when they fall due until 28 February 2027 and that they have the ability to provide this support.”
Group structure
- PHARMA INTELLIGENCE U.K. LIMITED · parent
- J&D Consulting Ltd 100%
Significant events
- “During fiscal year 2024 and 2023, the Company made distributions without having sufficient distributable reserves. Specifically: On 1 April 2024, J&D Consulting Limited, a wholly owned subsidiary of the Company, transferred contracts to Evaluate Limited, a sister entity, for no consideration, constituting a distribution in kind under section 829 of the Companies Act 2006. The Company surrendered £1,281 thousands of its tax losses to other members of the Company's group as of the period ended 31 December 2023.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
1 active · 12 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| GALLUP, Michael Douglas | Director | 2026-03-11 | Nov 1973 | American |
Show 12 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| INFORMA COSEC LIMITED | Corporate Secretary | 2021-12-07 | 2022-06-01 |
| ADRIAN, Carl Sheldon | Director | 2021-12-07 | 2022-06-01 |
| BANE, Simon Robert | Director | 2021-12-07 | 2022-06-01 |
| BAYDAR, Cem Mehmet | Director | 2023-03-06 | 2023-09-07 |
| HARRIS, Vicky | Director | 2022-06-01 | 2024-09-06 |
| HASHEM, Ramsey | Director | 2022-06-01 | 2023-01-27 |
| MORGAN, Kevin Stephen | Director | 2023-09-07 | 2024-09-10 |
| NADLER, Jay | Director | 2024-09-27 | 2026-03-11 |
| NADLER, Jay | Director | 2022-06-01 | 2023-03-06 |
| PERKINS, Nicholas Michael | Director | 2021-12-07 | 2022-06-01 |
| RANDIGA, Levine Chris | Director | 2023-03-06 | 2024-09-27 |
| SIMON RABANAL, Roberto | Director | 2023-03-06 | 2024-07-31 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Caerus Uk 1 Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2022-06-01 | Active |
| Informa Uk Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2021-12-07 | Ceased 2022-06-01 |
Filing timeline
Last 20 of 60 total filings
Material constitutional events — rename, articles re-file, resolution
- 2026-01-09 RESOLUTIONS Resolution
- 2026-01-02 RESOLUTIONS Resolution
- 2024-11-26 MA Memorandum articles
- 2024-11-14 RESOLUTIONS Resolution
- 2024-10-06 RESOLUTIONS Resolution
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-03-11 | TM01 | officers | Termination director company with name termination date | |
| 2026-03-11 | AP01 | officers | Appoint person director company with name date | |
| 2026-01-09 | RESOLUTIONS | resolution | Resolution | |
| 2026-01-06 | AA | accounts | Accounts with accounts type full | |
| 2026-01-02 | SH20 | capital | Legacy | |
| 2026-01-02 | SH19 | capital | Capital statement capital company with date currency figure | |
| 2026-01-02 | CAP-SS | insolvency | Legacy | |
| 2026-01-02 | RESOLUTIONS | resolution | Resolution | |
| 2025-12-17 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-10-31 | RP01SH01 | miscellaneous | Legacy | |
| 2025-03-05 | AA | accounts | Accounts with accounts type full | |
| 2024-12-12 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2024-11-26 | MA | incorporation | Memorandum articles | |
| 2024-11-14 | RESOLUTIONS | resolution | Resolution | |
| 2024-11-04 | SH01 | capital | Capital allotment shares | |
| 2024-10-06 | RESOLUTIONS | resolution | Resolution | |
| 2024-09-30 | TM01 | officers | Termination director company with name termination date | |
| 2024-09-30 | AP01 | officers | Appoint person director company with name date | |
| 2024-09-10 | TM01 | officers | Termination director company with name termination date | |
| 2024-09-06 | TM01 | officers | Termination director company with name termination date |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 10
- Capital events
- 3
- Officers appointed
- 1
- Officers resigned
- 1
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.